This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Feline Insulin-like Growth Factor I (IGF1)
Product Overview
BioVenic's Recombinant Feline Insulin-like Growth Factor I (IGF1) is a recombinant protein expressed from E. coli expression system. Its predicted molecular weight is 7 kDa. The purity is greater than 95% (SDS-PAGE). The endotoxin level is <0.5 EU/μg (LAL).
Specifications
Target Information
Insulin like growth factor 1 is encoded by the IGF1 gene in cats. Insulin-like growth factor I (IGF1) belongs to the family of insulin-like growth factors that are structurally homologous to proinsulin. Mature IGFs are produced by proteolytic processing of an inactive precursor protein containing N- and C-terminal propeptide regions. It is structurally homologous to proinsulin.
Shipping and Storage
This product is shipped with dry ice. It is recommended to aliquote as needed and store at -20°C upon receipt. Reconstituted protein solution can be stored at 4°C for 1 week, at < -20°C for 3 months.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Dissolve the lyophilized protein in distilled water. Avoid mixing by vortexing or pipetting. It is not recommended to reconstitute to a concentration < 100 μg/mL. Aliquote the reconstituted solution to minimise freeze-thaw cycles.